Declining investment in global health surveillance, research, and scientific innovation are happening as the need for vigilance has never been greater, writes Robert C. Gallo.

Gavi, the vaccine provider for the world’s poorest people, needs an extra US$3 billion to protect infants and other ...

What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have found a way to do just that—by tweaking a key molecule in the vaccine’s ...

TAU’s vice president for research and development said that they worked on the project for two-and-a-half years and were very ...

To help with these questions about the plague, CNN spoke with wellness expert Dr. Leana Wen, an emergency physician and ...

Child mortality has been halved in the last 25 years. Building on this progress, new innovations in immunization are working ...

Researchers from Cornell and Northwestern universities have developed a rapid, cell-free method for building nanoparticle ...

A Coconino County resident died of a rare case of pneumonic plague earlier this month. Dave Wagner, director of Northern ...

An experimental mRNA vaccine has boosted the tumor-fighting effects of immunotherapy in a mouse-model study, bringing researchers one step closer to their goal of developing a universal vaccine to ...

Partial immunity from COVID in residents early in the pandemic and infection-prevention measures may explain the findings, ...

In contrast, the efficacy vaccines with one and two components varied from 59% to 78% in protecting against typical whooping cough and from 41% to 58% against mild pertussis disease. Most systemic and ...